Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 7,956 | 3,754 | 5,000 | 33 | 3,762 |
| Gross Profit | 7,956 | 3,754 | 5,000 | 33 | 3,762 |
| Operating Expenses | 39,729 | 38,360 | 30,866 | 21,438 | 22,911 |
| Operating Income | -31,773 | -34,606 | -25,866 | -21,405 | -19,149 |
| Interest Expense | 2,917 | 1,855 | 259 | 0 | 0 |
| Other Income | 92 | -7,490 | 5,984 | -3,182 | -21,077 |
| Pre-tax Income | -34,598 | -43,951 | -20,141 | -24,587 | -40,226 |
| Net Income Continuous | -34,598 | -43,951 | -20,141 | -24,587 | -40,226 |
| Net Income | $-34,598 | $-43,951 | $-20,141 | $-24,587 | $-40,226 |
| EPS Basic Total Ops | -138.58 | -191.07 | -90.29 | -207.87 | -2,477.63 |
| EPS Basic Continuous Ops | -139.04 | -191.67 | -91.12 | -207.66 | -1,469.67 |
| EPS Diluted Total Ops | -138.58 | -191.07 | -90.29 | -207.87 | -2,477.63 |
| EPS Diluted Continuous Ops | -139.04 | -191.67 | -91.12 | -207.66 | -1,469.67 |
| EBITDA(a) | $-31,132 | $-34,175 | $-25,754 | $-21,255 | $-18,807 |